Management of Refractory Pediatric Sarcoma: Current Challenges and Future Prospects

Area of Science:

• Pediatric Oncology
• Cancer Biology
• Translational Research

Background:

• Paediatric sarcomas, including bone and soft tissue types, frequently present with metastasis or recurrence.
• A significant unmet need exists for effective curative options and survival prolongation in this patient group.

Purpose of the Study:

• To review current treatment strategies for relapsed/refractory paediatric sarcomas.
• To discuss challenges and explore future directions in managing these complex cases.

Main Methods:

• Review of current treatment modalities for paediatric sarcomas.
• Analysis of challenges in managing relapsed/refractory disease.
• Exploration of novel therapeutic approaches and research directions.

Main Results:

• Upfront risk-adapted, multidisciplinary management is key for preventing recurrence.
• Multimodality treatment is an option for limited or late relapses.
• Treatment-refractory cases necessitate novel therapeutics, immunotherapy, targeted therapies, and metronomic therapies.

Conclusions:

• Further research into disease biology, treatment refractoriness mechanisms, and driver mutations is crucial.
• Discovery of novel targeted therapies, cellular vaccines, and adapted treatments is needed.
• National and international collaboration is essential for advancing translational research in relapsed/refractory paediatric sarcomas.